p53 Inhibition for iPS Cell Reprogramming Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The efficiency of establishing induced pluripotent stem (iPS) cells is low, particularly when using 3 factors (Oct3/4, Sox2, and Klf4) without c-Myc, which can lead to tumorigenesis, and it is challenging to produce iPS cells from T lymphocytes.
Innovation Solution
Inhibiting the p53 function during somatic cell nuclear reprogramming using chemical inhibitors, dominant negative mutants, siRNAs, or shRNAs against p53, which increases the efficiency of iPS cell establishment, especially with 3 factors, and allows for the production of iPS cells from T lymphocytes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If 3 factors (Oct3/4, Sox2, and Klf4) are used without c-Myc for iPS cell induction, then tumorigenesis risk is reduced, but establishment efficiency becomes extremely low
Solution Approach 1:
The patent extracts and removes c-Myc from the traditional 4-factor reprogramming system, using only 3 factors (Oct3/4, Sox2, and Klf4) to induce iPS cells. This extraction eliminates the tumorigenesis risk associated with c-Myc while accepting the trade-off of reduced establishment efficiency, which is then partially compensated by other optimization methods described in the patent.
2Productivity
If p53 function is inhibited to improve iPS cell establishment efficiency, then reprogramming efficiency increases, but cellular DNA damage response is suppressed
Solution Approach 1:
The patent applies preliminary action by inhibiting p53 function before initiating the reprogramming process. Chemical inhibitors such as Pifithrin-α are administered to somatic cells prior to transduction with reprogramming factors, pre-suppressing p53-mediated cell cycle arrest and apoptosis pathways. This preliminary suppression creates a permissive cellular environment that facilitates efficient reprogramming, allowing cells to overcome DNA damage responses that would otherwise block the transition to pluripotency.
Data Source
AI summary
The invention provides an in vitro method of improving the efficiency of establishment of induced pluripotent stem (iPS) cells. The method comprises contacting an isolated somatic cell being reprogrammed into an iPS cell with an inhibitor of p53 function. The invention also provides an in vitro method of producing iPS cells. The method comprises bringing (a) nuclear reprogramming substances or nucleic acids encoding the nuclear reprogramming substances and (b) an inhibitor of p53 function into contact with a somatic cell.